Dr Reddys Laboratories gains despite reporting 86% fall in Q4 consolidated net profit

12 May 2016 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2946.00, up by 76.80 points or 2.68% from its previous closing of Rs. 2869.20 on the BSE.

The scrip opened at Rs. 2845.00 and has touched a high and low of Rs. 2968.00 and Rs. 2845.00 respectively. So far 126081 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 2958.00 and Rs. 2825.00 respectively. The current market cap of the company is Rs. 49955.02 crore.

The promoters holding in the company stood at 25.58% while Institutions and Non-Institutions held 42.02% and 32.40% respectively.

Dr Reddys Laboratories has posted a net loss of Rs 5.7 crore for the quarter ended March 31, 2016 as compared to net profit of Rs 571.4 crore for the same quarter in the previous year. Total income of the company has decreased by 10.71% at Rs 2478.7 crore for quarter under review as compared to Rs 2776 crore for the quarter ended March 31, 2015.

On consolidated basis, the company has posted a fall of 85.62% in its net profit after taxes, minority interest and share of profit of associates  at Rs 74.6 crore for the quarter ended March 31, 2016 as compared to Rs 518.8 crore for the corresponding quarter in the FY15. Total income of the company decreased by 2.47% at Rs 3786.9 crore for quarter under review as compared to Rs 3882.9 crore for the same quarter ended previous year.

For the year ended March 31, 2016, the company has posted a fall of 19.35% in its net profit at Rs 1354.5 crore as compared to Rs 1679.4 crore for the same period in the previous year. However, total income of company increased 2.14% at Rs 10452.5 crore for year under review as compared to Rs 10233.8 crore for the period ended March 31, 2015. 

For the year ended March 31, 2016, on the consolidated basis, the company has posted a fall of 9.77% in its net profit after taxes, minority interest and share of profit of associates at Rs 2001.3 crore as compared to Rs 2217.9 crore for the same period in the previous year. However, total income of company has increased by 4.34% at Rs 15558.2 crore for year under review as compared to Rs 14910.6 crore for the period ended March 31, 2015.

 

Dr. Reddys Lab Share Price

1175.00 -0.55 (-0.05%)
19-Jan-2026 13:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.10
Dr. Reddys Lab 1175.00
Cipla 1388.40
Zydus Lifesciences 870.05
Lupin 2178.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×